Antiemetic Market Report: Trends, Forecast and Competitive Analysis to 2030

Antiemetic Trends and Forecast The future of the global antiemetic market looks promising with opportunities in the chemotherapy, post operative surgery, and pregnancy & gatroenteritis markets. The global antiemetic market is expected to reach an estimated $11.5 billion by 2030 with a CAGR of 6.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of nausea and vomiting, growing number of gastroenteritis patients, and rising government funding for research. A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below. Antiemetic by Segment The study includes a forecast for the global antiemetic by drug type, distribution channel, aplication, and region. Antiemetic Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:

• Antihistamines

• Serotonin Receptor Antagonists

• Dopamine Receptor Antagonists

• Neurokinin Receptor Antagonists

• Anticholinergics

• Others Antiemetic Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Retail Pharmacies

• Hospital Pharmacies

• Online Pharmacies Antiemetic Market by Aplication [Shipment Analysis by Value from 2018 to 2030]:

• Chemotherapy

• Post Operative Surgery

• Pregnancy & Gatroenteritis

• Others Antiemetic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America

• Europe

• Asia Pacific

• The Rest of the World List of Antiemetic Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antiemetic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antiemetic companies profiled in this report include-

• Abbott Laboratories,

• Benuvia Therapeutics

• Cipla

• Dr. Reddy’s Laboratories

• Eisai

• F. Hoffmann-La Roche

• Merck

• Novartis

• Pfizer

• Teva Pharmaceuticals Antiemetic Market Insights Lucintel forecasts that serotonin receptor antagonist will remain the largest segment over the forecast period due to the increase in demand for gravisetron and ondansetron, which are used to reduce nausea and vomiting following surgical operations.. Within this market, chemotherapy will remain the largest segment due to the increase in cancer diagnoses and the corresponding increase in the use of chemotherapy as a form of treatment. APAC will remain the largest region over the forecast period due to surge in cancer population and growing incidences of gastroenteritis, and other diseases in the region. Features of the Global Antiemetic Market Market Size Estimates: Antiemetic market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Antiemetic market size by drug type, distribution channel, aplication, and region in terms of value ($B). Regional Analysis: Antiemetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different drug types, distribution channels, aplications, and regions for the antiemetic market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antiemetic market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. FAQ Q1. What is the antiemetic market size? Answer: The global antiemetic market is expected to reach an estimated $11.5 billion by 2030. Q2. What is the growth forecast for antiemetic market? Answer: The global antiemetic market is expected to grow with a CAGR of 6.0% from 2024 to 2030. Q3. What are the major drivers influencing the growth of the antiemetic market? Answer: The major drivers for this market are increasing prevalence of nausea and vomiting, growing number of gastroenteritis patients, and rising government funding for research. Q4. What are the major segments for antiemetic market? Answer: The future of the antiemetic market looks promising with opportunities in the chemotherapy, post operative surgery, and pregnancy & gatroenteritis markets. Q5. Who are the key antiemetic market companies? Answer: Some of the key antiemetic companies are as follows:

• Abbott Laboratories,

• Benuvia Therapeutics

• Cipla

• Dr. Reddy’s Laboratories

• Eisai

• F. Hoffmann-La Roche

• Merck

• Novartis

• Pfizer

• Teva Pharmaceuticals Q6. Which antiemetic market segment will be the largest in future? Answer: Lucintel forecasts that serotonin receptor antagonist will remain the largest segment over the forecast period due to the increase in demand for gravisetron and ondansetron, which are used to reduce nausea and vomiting following surgical operations.. Q7. In antiemetic market, which region is expected to be the largest in next 5 years? Answer: APAC will remain the largest region over the forecast period due to surge in cancer population and growing incidences of gastroenteritis, and other diseases in the region. Q.8 Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the antiemetic market by drug type (antihistamines, serotonin receptor antagonists, dopamine receptor antagonists, neurokinin receptor antagonists, anticholinergics, and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies), aplication (chemotherapy, post operative surgery, pregnancy & gatroenteritis, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to Antiemetic Market, Antiemetic Market Size, Antiemetic Market Growth, Antiemetic Market Analysis, Antiemetic Market Report, Antiemetic Market Share, Antiemetic Market Trends, Antiemetic Market Forecast, Antiemetic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.